This collection examines Europe’s harm reduction journey, including early successes, uneven implementation, securitisation, stigma and medicalisation; and proposes a reframed, people-led approach centring wellbeing, acknowledging drug-use benefits, and advancing rights-based reforms.
IDPC calls on the European Commission to ensure the next Strategy is balanced, evidence-based, and rights-centred, prioritising harm reduction, civil society participation, and policy innovation over punitive approaches.
The CSFD calls for an EU Drugs Strategy that puts health, human rights and equity at its core — moving from political statements to real action, with civil society as a full partner.
Ukraine has approved a new National Drug Policy strategy, which aims to improve access to controlled medicines, expand harm reduction programmes, and provide support to marginalized populations.
C-EHRN urges the European Commission to reconsider its decision to eliminate EU4Health operating grants, warning that it endangers vital public health and human rights protections.
The 2025 EU Drug Report uncovers a rapidly evolving drug landscape, fuelled by synthetic substances, tech innovation, and global instability. With rising health and security threats, the report places urgent emphasis on real-time data, early warning systems, and bold cross-sector collaboration.
As the EU prepares its 2026–2030 Drug Strategy, we call for a balanced, health-oriented approach that prioritises harm reduction and rights protections instead of punishment.
The upcoming strategy Drug Strategy offers an opportunity to remediate the lack of adequate support for harm reduction services and promote health outcomes and rights.
C-EHRN's civil society monitoring identifies necessary but unequal progress on treatment and access to services, decrying enduring challenges related to funding, legislation, stigma and political will.
Join C-EHRN’s webinar on 9 May to explore Europe’s emerging nitazene threat, addressing trends, health risks, policy responses, and harm reduction strategies.
